Nano Flow’s Anti-VIM gold conjugate is based on a monoclonal antibody targeting Verona Integron-Mediated Metallo-beta-lactamase (VIM), a major antimicrobial resistance marker in Gram-negative bacteria. Validated as a detection antibody in lateral flow assays, it ensures highly specific and reproducible detection of VIM-producing bacteria. The corresponding capture antibody is also available, providing developers with a complete pair solution for rapid diagnostic assay design.
Anti-VIM Gold Conjugate – 40 nm (Ref NF-VIM-AU)
This conjugate demonstrates no cross-reactivity with other carbapenemases, ensuring diagnostic precision. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it guarantees reproducibility, long-term stability, and strong visual signal intensity across assay formats.
Applications: Lateral flow assays (LF) and other immunoassay platforms for antimicrobial resistance detection.
Certificate of Analysis: Supplied with each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG2b |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | Verona Integron-Mediated Metallo-beta-lactamase (VIM) |
| Cross-reactivity | None with other carbapenemases |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
